Adesuwa Eguaze, PT, DPT in Selkirk, NY - Physical Therapist

Adesuwa Eguaze, PT, DPT is a Physical Therapist based in Selkirk, New York. Adesuwa Eguaze is licensed to practice in New York (license number 043125) and her current practice location is 15 Ruby Ln, Selkirk, New York. She can be reached at her office (for appointments etc.) via phone at (518) 902-9415.

NPI number for Adesuwa Eguaze is 1023598604 and her current mailing address is 15 Ruby Ln, Selkirk, New York. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1023598604.

Contact Information

	Adesuwa Eguaze, PT, DPT
	15 Ruby Ln, Selkirk, NY 12158-3016
	(518) 902-9415
	Not Available

Healthcare Provider's Profile

Full Name	Adesuwa Eguaze
Gender	Female
Speciality	Physical Therapist
Location	15 Ruby Ln, Selkirk, New York
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1023598604
Provider Enumeration Date: 08/14/2018
Last Update Date: 01/14/2024

Medical Identifiers

Medical identifiers for Adesuwa Eguaze such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1023598604	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
225100000X	Physical Therapist	043125 (New York)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Adesuwa Eguaze is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Adesuwa Eguaze, PT, DPT 15 Ruby Ln, Selkirk, NY 12158-3016 Ph: (518) 902-9415	Adesuwa Eguaze, PT, DPT 15 Ruby Ln, Selkirk, NY 12158-3016 Ph: (518) 902-9415

News Archive

New applications for proton pump inhibitors

In a new study, published in the May issue of Elsevier's Experimental Neurology (www.elsevier.com/locate/yexnr), scientists at the University of British Columbia have discovered that drugs commonly used to treat ulcers have significant neuroprotective properties, which appear to be enhanced when used in combination with ibuprofen, a widely used anti-inflammatory drug.

Investigational three-drug combination clears hepatitis C in 93% of patients with liver cirrhosis

A 12-week dose of an investigational three-drug hepatitis C combination cleared the virus in 93 percent of patients with liver cirrhosis who hadn't previously been treated, according to a study in the May 5, 2015, issue of The Journal of the American Medical Association.

Scientists receive critical funding to study treatments for three deadly cancers

Immunotherapy for leukemia patients has been nothing short of a miracle. Now scientists hope to use that science and other forms of gene therapy to tackle three of the deadliest forms of cancer: glioblastoma (brain cancer), sarcoma (bone cancer) and ovarian cancer.

Novel controlled clinical trial finds Ayurvedic-based well-being program can alter blood-based metabolites

In a novel controlled clinical trial, participants in a six-day Ayurvedic-based well-being program that featured a vegetarian diet, meditation, yoga and massages experienced measurable decreases in a set of blood-based metabolites associated with inflammation, cardiovascular disease risk and cholesterol regulation.

Adesuwa Eguaze, PT, DPT - Physical Therapist in Selkirk, NY